Ionis gets approval for preventing attacks in rare and genetic HAE
In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as…
Injecting medicine into amniotic fluid shows promise for treating genetic disorders
Injecting medicine into the amniotic fluid staves off progression of spinal muscular atrophy in utero. Evidence is mounting…
Injecting medicine into amniotic fluid shows promise for treating genetic disorders
Injecting medicine into the amniotic fluid staves off progression of spinal muscular atrophy in utero. Evidence is mounting…